cbdMD, Inc. (YCBD)
0.5025
0.00 (0.00%)
USD |
NYAM |
Sep 03, 09:38
cbdMD Cash from Investing (Quarterly) : -0.0181M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0181M |
| March 31, 2026 | 0.0507M |
| December 31, 2025 | -0.1648M |
| September 30, 2025 | -0.0028M |
| June 30, 2025 | -0.0015M |
| March 31, 2025 | -0.0155M |
| December 31, 2024 | -0.1644M |
| September 30, 2024 | -0.11M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.0046M |
| December 31, 2023 | -0.1846M |
| September 30, 2023 | -0.1202M |
| June 30, 2023 | -0.1024M |
| March 31, 2023 | 1.102M |
| December 31, 2022 | -0.1774M |
| September 30, 2022 | 0.0956M |
| June 30, 2022 | -0.4104M |
| March 31, 2022 | -0.1428M |
| Date | Value |
|---|---|
| December 31, 2021 | -0.231M |
| September 30, 2021 | -2.030M |
| June 30, 2021 | 0.455M |
| March 31, 2021 | -1.423M |
| December 31, 2020 | 0.4467M |
| September 30, 2020 | 0.2817M |
| June 30, 2020 | -0.0554M |
| March 31, 2020 | -1.241M |
| December 31, 2019 | -0.5557M |
| September 30, 2019 | -0.5271M |
| June 30, 2019 | -0.2466M |
| March 31, 2019 | -0.0925M |
| December 31, 2018 | -1.268M |
| September 30, 2018 | -0.0211M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | -0.3598M |
| December 31, 2017 | -0.3027M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| The Cannabist Company Holdings, Inc. | 29.96M |
| Tilray Brands, Inc. | -51.39M |
| Organogenesis Holdings, Inc. | -1.10M |
| Guardian Pharmacy Services, Inc. | -3.732M |
| Nektar Therapeutics | -399.11M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.4422M |
| Cash from Financing (Quarterly) | -0.0597M |
| Free Cash Flow | -2.409M |
| Free Cash Flow Per Share (Quarterly) | -0.0434 |
| Free Cash Flow to Equity (Quarterly) | -2.258M |
| Free Cash Flow to Firm (Quarterly) | -0.4603M |
| Free Cash Flow Yield | -49.20% |